🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this research study is to determine the maximum tolerab...
Status
Active Not Recruiting
Location
University of Rochester
Start Date
2020-11-23
Trial ID
NCT04477343
Treatments Being Tested
The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Status
Unknown
Location
National University Hospital
Start Date
2019-02-21
Trial ID
NCT03784040
Treatments Being Tested
This is a feasibility study in patients with localized or metastatic soft t...
Status
Completed
Location
Monter Cancer Center (Northwell Health)
Start Date
2016-12-15
Trial ID
NCT03056599
Treatments Being Tested
The study aims to evaluate the 6 month-treatment tolerance defined as the i...
Status
Completed
Location
Gustave Roussy
Start Date
2016-12-05
Trial ID
NCT02857569
Treatments Being Tested
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
The purpose of this study is to determine whether the combination of a neoa...
Status
Not Yet Recruiting
Location
Johns Hopkins SKCCC
Start Date
2026-09
Trial ID
NCT07430202
Treatments Being Tested
This study aims to evaluate the safety, tolerability and effectiveness of n...
Status
Unknown
Location
Border Medical Oncology
Start Date
2017-10-19
Trial ID
NCT03177239
Treatments Being Tested
This is a multi-center, open-label Phase 0 Master Protocol in Australia des...
Status
Withdrawn
Location
Chris O'Brien Lifehouse
Start Date
2021-09-15
Trial ID
NCT04891718
Treatments Being Tested
This study study aims to elucidate the immune responses to a shared antigen...
Status
Completed
Location
Washington University School of Medicine
Start Date
2018-09-14
Trial ID
NCT03532217
This is a Phase II trial to determine the efficacy and safety of in situ ge...
Status
Terminated
Location
Houston Methodist Hospital
Start Date
2017-02-15
Trial ID
NCT02831933
Treatments Being Tested